|
2019
|
Invention
|
Combination formulation of two antiviral compounds.
Disclosed are pharmaceutical compositions ha... |
|
|
Invention
|
Antiviral compounds.
The invention is related to anti-viral compounds, compositions containing s... |
|
|
Invention
|
Inhibitors of hepatitis c virus. Compounds of Formula I are disclosed
As well as pharmaceuti... |
|
|
Invention
|
Antiviral compounds.
The disclosure is related to anti-viral compounds, compositions containing ... |
|
2018
|
Invention
|
Modified fluorinated nucleoside analogues.
The disclosed invention provides compositions and met... |
|
|
Invention
|
Combination formulation of two antiviral compounds.
Disclosed are pharmaceutical compositions co... |
|
|
Invention
|
Inhibitors of hepatitis c virus. Compounds of Formula I are disclosed
As well as pharmaceutical... |
|
2017
|
Invention
|
Processes for preparing antiviral compounds.
The present disclosure provides processes for the p... |
|
|
Invention
|
Combination formulation of three antiviral compounds. Disclosed are pharmaceutical compositions c... |
|
|
Invention
|
Methods of treating hepatitis e viral infection. Disclosed herein are methods of treating a hepat... |
|
|
Invention
|
Solid forms of an antiviral compound.
Amorphous and crystalline solid forms of the anti-HCV comp... |
|
|
Invention
|
Inhibitors of hepatitis c virus.
Compounds of Formula I are disclosed
Compounds of Formula I a... |
|
|
Invention
|
Nucleoside phosphoramidates.
Disclosed herein are nucleoside phosphoramidates and their use as a... |
|
|
Invention
|
Compositions and methods for treating hepatitis c virus.
Disclosed herein are a composition and ... |
|
2016
|
Invention
|
Crystalline forms of an antiviral compound. Crystalline forms of the anti-HCV compound (1aR,5S,8S... |
|
|
Invention
|
Methods for treating hcv.
This invention relates to combinations of therapeutic molecules useful... |
|
2015
|
Invention
|
Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrim... |
|
|
Invention
|
Solid forms of an antiviral compound. Crystalline solid forms of methyl {(2S)-1-[(2S,5S)-2-(9-{2-... |
|
|
Invention
|
Processes for preparing antiviral compounds. The present disclosure provides processes for the pr... |
|
|
Invention
|
Synthesis of antiviral compound.
The present disclosure provides processes for the preparation o... |
|
2014
|
Invention
|
Synthesis of an antiviral compound. The present disclosure provides processes for the preparation... |
|
|
Invention
|
Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide. Crystalline forms of the anti-H... |
|
|
Invention
|
Crystalline forms of antiviral sofosbuvir analogues. Crystalline solid forms of the anti-HCV comp... |
|
|
Invention
|
Methods of treating hepatitis c virus infection in subjects with cirrhosis. Methods of treating h... |
|
|
Invention
|
Methods of treating hepatitis c virus infection in subjects with cirrhosis.
Methods of treating ... |
|
|
Invention
|
Solid forms of an antiviral compound. Crystalline solid forms and the amorphous form of the anti-... |
|
|
Invention
|
Preventing and treating recurrence of hcv infection after liver transplant. This application desc... |
|
|
Invention
|
Methods of preventing and treating recurrence of a hepatitis c virus infection in a subject after... |
|
|
Invention
|
Solid dispersion formulation of an antiviral compound.
Disclosed are solid dispersions comprisin... |
|
|
Invention
|
Combination formulation of two antiviral compounds. Disclosed are pharmaceutical compositions com... |
|
|
Invention
|
Solid dispersion formulation of an antiviral compound. Disclosed are solid dispersions comprising... |
|
|
Invention
|
Hepatitis c treatment.
Disclosed are methods for treating hepatitis C in a human patient in need... |
|
|
Invention
|
Hepatitis c treatments with sofosbuvir. Disclosed are methods for treating hepatitis C in a human... |
|
2013
|
Invention
|
Inhibitors of hepatitis c virus.
Compounds of Formula I are disclosed, As well as pharmaceutical... |
|
|
Invention
|
Crystal structure of hcv polymerase complexes and methods of use.
The present disclosure include... |
